Safety Study of a Recombinant Human Plasminogen Activator to Treat Acute Ischemic Stroke.

Completed

Phase 1/2 Results

Summary of Purpose

To evaluate the safety profiles of HTU-PA in patients with acute ischemic stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 3 January 2007.

1 Apr 2001 3 Jan 2007 Unavailable 1 Jun 2004 1 Dec 2006 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Non-Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Single Group Assignment

Contacts

Not available